Trials / Completed
CompletedNCT01413061
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- AlloSource · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to evaluate the outcome of implanting AlloStem® graft with appropriate rigid internal fixation hardware as an alternative to autograft bone graft with rigid fixation in subtalar arthrodesis procedures. The primary objective of this clinical trial is to compare the overall fusion rate of the investigational to the control treatment. Fusion will be determined by clinical findings, radiographs and computed tomography (CT) of the subtalar joint 24 weeks (6 months) after the trial surgery.
Conditions
- Degenerative Osteoarthritis
- Post-traumatic; Arthrosis
- Rheumatoid Arthritis & Other Inflammatory Polyarthropathies
- Rheumatoid Arthritis of Subtalar Joint
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Subtalar Arthrodesis |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2017-02-01
- Completion
- 2018-03-01
- First posted
- 2011-08-10
- Last updated
- 2018-04-13
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01413061. Inclusion in this directory is not an endorsement.